tailieunhanh - Guideline for Management of the Clinical Stage 1 Renal Mass

Consensus is always difficult. Even in the setting of level I evidence, competing interpretations, experiences and interests present challenges to the best-intentioned analyses. Consensus requires commitment to the process, time, a spirit of collaboration and, above all, leadership. For many, Andy Novick’s career was both the quintessence of leadership and the embodiment of the best in academic urology. Andy’s clinical and intellectual contributions in the fields of kidney transplantation and renovascular surgery provided the underpinning upon which surgical and functional renal preservation in cases of kidney cancer is based. He brought forward many of the concepts and techniques for nephron-sparing surgery. Perhaps most importantly, Andy facilitated the recognition that. | Guideline for Management of the Clinical Stage 1 Renal Mass American Urological Association Education and Research Inc. Renal Mass Clinical Panel Members Andrew C. Novick MD Chair Steven C. Campbell MD PhD Co-Chair Arie Belldegrun MD Michael L. Blute MD George Kuoche Chow MD Ithaar H. Derweesh MD Jihad H. Kaouk MD Raymond J. Leveillee MD FRCS-G Surena F. Matin MD Paul Russo MD Robert Guy Uzzo MD Consultants Mar tha M. Faraday PhD Linda Whetter DVM PhD Michael Marberger MD AUA Staff Heddy Hubbard PhD FAAN Edith Budd Michael Folmer Katherine Moore Kadiatu Kebe Dedication to Andrew C. Novick . Consensus is always difficult. Even in the setting of level I evidence competing interpretations experiences and interests present challenges to the best-intentioned analyses. Consensus requires commitment to the process time a spirit of collaboration and above all leadership. For many Andy Novick s career was both the quintessence of leadership and the embodiment of the best in academic urology. Andy s clinical and intellectual contributions in the fields of kidney transplantation and renovascular surgery provided the underpinning upon which surgical and functional renal preservation in cases of kidney cancer is based. He brought forward many of the concepts and techniques for nephron-sparing surgery. Perhaps most importantly Andy facilitated the recognition that nephron-sparing surgery was safe feasible and oncologically sound through the systematic study and publication of his work as well as thoughtful review of the work of colleagues. He moved the field forward by believing that technology could improve care but insisting on responsible application and repetitive reassessment of the data as a means of doing so. Andy was an ardent supporter of basic and translational science in urology in both word and deed. He was a passionate educator and served our national organizations such as the American Board of Urology with pride and conviction. In the midst of all this he .

crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.